- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (600329)
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited stock price live, this page displays SS 600329 stock exchange data. View the 600329 premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited real time stock price chart below.
What Is the Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Stock Price Today?
The Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited stock price today is 40.78.
What Is the Stock Symbol for Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited?
The stock symbol for Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited is "600329."
What Stock Exchange Does Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Trade On?
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited is listed and trades on the Shanghai stock exchange.
Is Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited a Good Stock to Buy?
Determining whether Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 600329 quote. (ISIN: CNE000001808)
What Is the Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Stock Price Today?
The Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited stock price today is 40.78.
What Is the Stock Symbol for Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited?
The stock symbol for Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited is "600329."
What Stock Exchange Does Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Trade On?
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited is listed and trades on the Shanghai stock exchange.
Is Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited a Good Stock to Buy?
Determining whether Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 600329 quote. (ISIN: CNE000001808)
40.78
-0.14(-0.34%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
40.13
42.70
52 wk Range
33.83
50.95
Earnings results expected in 3 days
1/3
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
40.1342.70
52 wk Range
33.8350.95
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
600329 Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Price Target
0.00
Downside
-100.00%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
High shareholder yield
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy
Analyst Ratings
1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 0.00
Earnings
Latest Release
Aug 14, 2026
EPS / Forecast
0.29 / --
Revenue / Forecast
939.39M / --
Compare 600329 to Peers and Sector
Metrics to compare | 600329 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship600329PeersSector | |
|---|---|---|---|---|
P/E Ratio | 32.0x | 18.5x | −0.3x | |
PEG Ratio | −0.42 | 1.09 | 0.00 | |
Price/Book | 4.6x | 2.4x | 2.6x | |
Price / LTM Sales | 5.7x | 2.6x | 2.9x | |
Upside (Analyst Target) | - | 29.2% | 62.0% | |
Fair Value Upside | Unlock | 14.9% | 9.5% | Unlock |
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited engages in the research, development, processing, manufacturing, and sale of traditional Chinese medicine in China. It provides pharmaceutical products for cardiovascular and cerebrovascular, skin wound repair, health preservation, respiratory, digestion, rheumatism and osteodynia, urological, gynecological and pediatric, ophthalmological, tumor, chronic, and other diseases, as well as tonic drugs. The company was formerly known as Tianjin Zhong Xin Pharmaceutical Group Corporation Limited and changed its name to Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited in May 2022. The company was founded in 1915 and is based in Tianjin, the People’s Republic of China.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the DRTG (600329) Stock Price Today?
The DRTG stock price today is 40.78 CNY.
What Stock Exchange Does DRTG Trade On?
DRTG is listed and trades on the Shanghai Stock Exchange.
What Is the Stock Symbol for DRTG?
The stock symbol for DRTG is "600329."
Does DRTG Pay Dividends? What’s The Current Dividend Yield?
The DRTG dividend yield is 11.7%%.
What Is the DRTG Market Cap?
As of today, DRTG market cap is 13.68B CNY.
What Is DRTG's Earnings Per Share (TTM)?
The DRTG EPS (TTM) is 1.10.
When Is the Next DRTG Earnings Date?
DRTG will release its next earnings report on Oct 23, 2026.
From a Technical Analysis Perspective, Is 600329 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has DRTG Stock Split?
DRTG has split 2 times.
How Many Employees Does DRTG Have?
DRTG has 3890 employees.
What is the current trading status of DRTG (600329)?
As of Oct 20, 2026, DRTG (600329) is trading at a price of 40.78 CNY, with a previous close of 40.92 CNY. The stock has fluctuated within a day range of 40.13 CNY to 42.70 CNY, while its 52-week range spans from 33.83 CNY to 50.95 CNY.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.